Total Payments
$1,727
2024 Payments
$1,667
Companies
6
Transactions
14
Medicare Patients
1,567
Medicare Billing
$170,737
Payment Breakdown by Category
Consulting$1,515 (87.7%)
Food & Beverage$211.84 (12.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $1,515 | 1 | 87.7% |
| Food and Beverage | $211.84 | 13 | 12.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $1,580 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $52.74 | 3 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33.21 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $28.92 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $16.51 | 1 | $0 (2024) |
| Mylan Specialty L.P. | $15.31 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,667 | 11 | GENZYME CORPORATION ($1,553) |
| 2023 | $17.14 | 1 | Regeneron Healthcare Solutions, Inc. ($17.14) |
| 2022 | $42.60 | 2 | GENZYME CORPORATION ($27.29) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: Immunology | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.51 | General |
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: RESPIRATORY | ||||||
| 11/06/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,515.00 | General |
| 09/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: Immunology | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $9.20 | General |
| Category: Immunology | ||||||
| 05/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug), STIOLTO RESPIMAT | Food and Beverage | In-kind items and services | $33.21 | General |
| Category: RESPIRATORY | ||||||
| 03/01/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $7.08 | General |
| Category: Immunology | ||||||
| 03/22/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/30/2022 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: Immunology | ||||||
| 03/02/2022 | Mylan Specialty L.P. | Yupelri (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Anticholinergics, Inhaled | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 419 | 514 | $117,073 | $36,853 |
| 2022 | 12 | 541 | 2,922 | $175,632 | $51,266 |
| 2021 | 13 | 508 | 3,696 | $222,668 | $63,605 |
| 2020 | 5 | 99 | 160 | $58,804 | $19,012 |
Total Patients
1,567
Total Services
7,292
Medicare Billing
$170,737
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 41 | 77 | $45,661 | $12,149 | 26.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 72 | $21,316 | $9,199 | 43.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 27 | $5,859 | $2,427 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 25 | $5,503 | $2,208 | 40.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 51 | 56 | $5,990 | $1,945 | 32.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 14 | 24 | $6,480 | $1,867 | 28.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,524 | $1,375 | 30.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 11 | $3,212 | $1,129 | 35.2% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 31 | 31 | $3,347 | $1,099 | 32.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 41 | 41 | $5,958 | $1,074 | 18.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 15 | $2,295 | $935.25 | 40.8% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 34 | 39 | $3,513 | $627.68 | 17.9% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 12 | 13 | $949.00 | $286.68 | 30.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 21 | 21 | $1,008 | $160.20 | 15.9% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 24 | 24 | $600.00 | $159.85 | 26.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 16 | 16 | $528.00 | $140.10 | 26.5% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 11 | 11 | $330.00 | $70.40 | 21.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 63 | 110 | $64,240 | $17,896 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 47 | 72 | $21,168 | $9,008 | 42.6% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 28 | 60 | $15,960 | $5,209 | 32.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 45 | $9,585 | $3,611 | 37.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $7,999 | $3,137 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 36 | $7,992 | $3,111 | 38.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 70 | 71 | $7,707 | $2,961 | 38.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $4,836 | $1,866 | 38.6% |
About Dr. Kevin Patterson, M.D
Dr. Kevin Patterson, M.D is a Pulmonary Disease healthcare provider based in Grand Rapids, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2014. The National Provider Identifier (NPI) number assigned to this provider is 1457779274.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Patterson, M.D has received a total of $1,727 in payments from pharmaceutical and medical device companies, with $1,667 received in 2024. These payments were reported across 14 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($1,515).
As a Medicare-enrolled provider, Patterson has provided services to 1,567 Medicare beneficiaries, totaling 7,292 services with total Medicare billing of $170,737. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Grand Rapids, MI
- Active Since 03/29/2014
- Last Updated 05/20/2024
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1457779274
Products in Payments
- DUPIXENT (Biological) $117.89
- SPIRIVA RESPIMAT (Drug) $33.21
- TRELEGY ELLIPTA (Drug) $15.57
- Yupelri (Drug) $15.31
- NUCALA (Biological) $13.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Grand Rapids
Dr. John Egan, M.d, M.D
Pulmonary Disease — Payments: $18,982
Pulmonary Disease $18,982
Eric Geiser, Md, MD
Pulmonary Disease — Payments: $10,902
Pulmonary Disease $10,902
Dr. Jason Wells, M.d, M.D
Pulmonary Disease — Payments: $8,174
Pulmonary Disease $8,174
Maximiliano Tamae Kakazu, Md, MD
Pulmonary Disease — Payments: $7,622
Pulmonary Disease $7,622
Dr. Matthew Karulf, M.d, M.D
Pulmonary Disease — Payments: $5,183
Pulmonary Disease $5,183
Malik Khan, M.d, M.D
Pulmonary Disease — Payments: $3,629
Pulmonary Disease $3,629